胰管支架联合吲哚美辛栓对困难胆管插管术后胰腺炎的预防作用分析
作者:
作者单位:

1.南京医科大学附属杭州医院消化内科;2.浙江省中西医结合胆胰疾病重点实验室;3.杭州市第一人民医院消化内科

作者简介:

通讯作者:

中图分类号:

基金项目:

浙江省医药卫生科技计划项目(2021ZH003,2021441076);杭州市科技发展计划项目(202004A14);杭州市医学高峰学科


Pancreatic duct stent combined with indomethacin suppository for prevention of pancreatitis after difficult bile duct intubation during endoscopic retrograde cholangiopancreatography
Author:
Affiliation:

Department of Gastroenterology, Hangzhou Hospital Affiliated to Nanjing Medical University

Fund Project:

Zhejiang Medical and Health Science and Technology Plan (2021ZH003, 2021441076); Hangzhou Science and Technology Development Plan (202004A14); Hangzhou Medical Peak Discipline

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 文章评论
    摘要:

    目的 探索胰管支架联合吲哚美辛栓直肠给药对内镜逆行胰胆管造影术(endoscopic retrograde cholangiopancreatography, ERCP)困难插管术后胰腺炎(post‑ERCP pancreatitis, PEP)的预防作用。方法 2019年1月—2021年12月在南京医科大学附属杭州医院行ERCP治疗的胆道疾病患者术前30 min予吲哚美辛栓100 mg纳肛,将术中发生困难胆管插管的患者(n=204)纳入本研究。根据随机数字数表将患者分为两组,联合组术中置入胰管支架(n=104),吲哚美辛组不置入支架(n=100)。比较两组术后高淀粉酶血症及PEP的发生率。结果 联合组术后高淀粉酶血症[21.2%(22/104)比34.0%(34/100),χ2=4.22,P=0.040]及PEP发生率[14.4%(15/104)比32.0%(32/100),χ2=8.88,P=0.003]均明显低于吲哚美辛组,但两组重症PEP发生率之间差异无统计学意义[1.0%(1/104)比1.0%(1/100),χ2=0.001,P=0.978]。结论 与单用吲哚美辛栓直肠给药相比,联合胰管支架置入可进一步减少ERCP后高淀粉酶血症和PEP的发生。

    Abstract:

    Objective To explore the preventive effects of pancreatic duct stent combined with rectal administration of indomethacin suppository for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) after difficult bile duct intubation during endoscopic retrograde cholangiopancreatography (ERCP). Methods From January 2019 to December 2021, patients with biliary and pancreatic diseases undergoing ERCP in Hangzhou Hospital Affiliated to Nanjing Medical University were given 100 mg indomethacin suppository to anal canal 30 minutes before the operation. And those with difficult bile duct intubation during the operation (n=204) were included in this study. According to the random number table, they were divided into the combination group (implanted with pancreatic duct stent during the operation, n=104) and the indomethacin group (not implanted with stent, n=100). The incidences of hyperamylasemia and PEP were compared between the two groups. Results The incidences of postoperative hyperamylasemia [21.2% (22/104) VS 34.0% (34/100), χ2=4.22, P=0.040] and PEP [14.4% (15/104) VS 32.0% (32/100), χ2=8.88, P=0.003] in the combination group were significantly lower than those in the indomethacin group. There was no significant difference in the incidence of severe PEP between the two groups [1.0% (1/104) VS 1.0% (1/100),χ2=0.001, P=0.978]. Conclusion Compared with rectal administration of indomethacin suppository alone, the incidences of hyperamylasemia and PEP after difficult bile duct intubation during ERCP can be further reduced when it is combined with pancreatic duct stent placement.

    参考文献
    相似文献
    引证文献
引用本文

沙志虎,顾伟刚,金杭斌,等.胰管支架联合吲哚美辛栓对困难胆管插管术后胰腺炎的预防作用分析[J].中华消化内镜杂志,2023,40(4):302-307.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-03-07
  • 最后修改日期:2023-03-30
  • 录用日期:2022-06-06
  • 在线发布日期: 2023-04-03
  • 出版日期:
您是第位访问者

通信地址:南京市鼓楼区紫竹林3号《中华消化内镜杂志》编辑部   邮编:210003

中华消化内镜杂志 ® 2025 版权所有
技术支持:北京勤云科技发展有限公司